Sector Chart Torii Pharmaceutical Co., Ltd.

Equities

Market Closed - Japan Exchange Other stock markets 07:00:00 06/06/2024 BST			5-day change	1st Jan Change
3,695 ^JPY	-1.86%		-0.40%	+3.94%

05-15	Verrica Pharmaceuticals Amends Licensing Agreement With Torii Pharmaceutical for Phase 3 Trial of Ycanth	MT
05-15	Verrica Pharmaceuticals Inc. Announces Amendment to Collaboration and License Agreement with Torii Pharmaceutical Co. Ltd. to Fund Global Pivotal Phase 3 Clinical Trial to Study Ycanth for the Treatment of Common Warts	CI

Total Return

"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes